FFA
LKFT

Farther Finance Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Farther Finance Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Buy
404
+130
+47% +$3.69K ﹤0.01% 4302
2026
Q1 		$8.15K Buy
274
+129
+89% +$4.27K ﹤0.01% 4233
2025
Q4 		$4.74K Buy
145
+144
+14,400% +$4.65K ﹤0.01% 4335
2025
Q3 		$35 Buy
+1
New +$32 ﹤0.01% 4885
2025
Q1 		– Sell
-159
Closed -$4.02K – 4316
2024
Q4 		$4.37K Buy
+159
New +$4.43K ﹤0.01% 2728
2024
Q3 		– Sell
-77
Closed -$1.93K – 4049
2024
Q2 		$1.93K Buy
+77
New +$2.19K ﹤0.01% 2808

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Farther Finance Advisors's LKFT Position: Q2 2026 in Review

Farther Finance Advisors increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 47% in Q2 2026, buying an estimated $3.69K and bringing the position to 404 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4302.

Farther Finance Advisors first reported a position in LKFT in Q2 2024 and has held it in 6 quarters since. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Farther Finance Advisors held 404 shares of Lakefront Biotherapeutics American Depositary Shares worth $12.1K as of Q2 2026.
  • Farther Finance Advisors bought 130 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $3.69K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4302 holding.
  • Farther Finance Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2024 and has held it in 6 quarters since.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.